Anaptysbio Inc (ANAB)

09:54 AM

Rosnilimab phase 2b rheumatoid arthritis data to be presented at ACR - Investing.com

09:54 AM

09:20 AM

AnaptysBio Announces Late-Breaking Presentation of Phase 2b Trial Data for Rosnilimab in Rheumatoid Arthritis at ACR Convergence 2025 - Quiver Quantitative

09:20 AM

09:17 AM

Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025 - GlobeNewswire

09:17 AM

09:16 AM

AnaptysBio to present rosnilimab rheumatoid arthritis data at ACR meeting - StreetInsider

09:16 AM

09:15 AM

6‑Month JAK‑like Efficacy: Anaptys' Rosnilimab Phase 2b Accepted for ACR Late‑Breaking Oral Presentation - Stock Titan

09:15 AM

08:36 AM

Barclays Initiates Coverage on AnaptysBio (ANAB) with Overweight Rating | ANAB Stock News - GuruFocus

08:36 AM

08:28 AM

Can AnaptysBio Inc. stock beat market expectations this quarterJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com

08:28 AM

08:25 AM

Barclays Initiates AnaptysBio at Overweight With $78 Price Target - MarketScreener

08:25 AM

08:22 AM

AnaptysBio Inc. stock prediction for this weekQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com

08:22 AM

07:59 AM

Is AnaptysBio Inc. stock positioned well for digital economy2025 Key Lessons & Smart Money Movement Tracker - newser.com

07:59 AM

01:13 AM

Should you wait for a breakout in AnaptysBio Inc.July 2025 Levels & Safe Capital Investment Plans - newser.com

01:13 AM

12:28 PM

How AnaptysBio Inc. stock reacts to job market dataJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com

12:28 PM

Oct 12, 2025

How moving averages guide AnaptysBio Inc. tradingGold Moves & Risk Managed Investment Signals - newser.com

Oct 12, 2025

Oct 11, 2025

Q3 EPS Estimates for AnaptysBio Lifted by Leerink Partnrs - MarketBeat

Oct 11, 2025

Oct 10, 2025

Can AnaptysBio Inc. (AN6) stock resist broad market declinesWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Will AnaptysBio Inc. (AN6) stock outperform benchmarks2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com

Oct 10, 2025

Oct 09, 2025

AnaptysBio splits operations into two companies - MSN

Oct 09, 2025

Oct 09, 2025

Why AnaptysBio Inc. stock could outperform in 20252025 Institutional Moves & AI Powered Market Trend Analysis - newser.com

Oct 09, 2025

Oct 08, 2025

AnaptysBio's (ANAB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 08, 2025

AnaptysBio, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 08, 2025

Oct 08, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 08, 2025

Oct 03, 2025

HighMark Wealth Management LLC Raises Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat

Oct 03, 2025

Oct 03, 2025

Leerink Partnrs Decreases Earnings Estimates for AnaptysBio - MarketBeat

Oct 03, 2025

Oct 03, 2025

Custom strategy builders for tracking AnaptysBio Inc.Market Sentiment Report & Growth Focused Stock Reports - newser.com

Oct 03, 2025

Oct 03, 2025

Is AnaptysBio Inc. reversing from oversold territoryWeekly Trade Review & Daily Chart Pattern Signals - newser.com

Oct 03, 2025

Oct 03, 2025

Applying sector rotation models to AnaptysBio Inc.2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com

Oct 03, 2025

Oct 03, 2025

Chart overlay techniques for tracking AnaptysBio Inc.July 2025 Short Interest & Safe Capital Growth Stock Tips - newser.com

Oct 03, 2025

Oct 02, 2025

Is AnaptysBio Inc. (AN6) stock good for long term investingEarnings Miss & Breakout Confirmation Alerts - newser.com

Oct 02, 2025

Oct 02, 2025

AnaptysBio (NASDAQ:ANAB) Stock Price Down 5.9%Time to Sell? - MarketBeat

Oct 02, 2025

Oct 02, 2025

HC Wainwright Analysts Cut Earnings Estimates for AnaptysBio - MarketBeat

Oct 02, 2025

Oct 02, 2025

Biggest stock movers today: UUUU, FLY, and more - MSN

Oct 02, 2025

Oct 02, 2025

AnaptysBio (NASDAQ:ANAB) Trading 8.9% Higher After Analyst Upgrade - Defense World

Oct 02, 2025

Oct 01, 2025

AnaptysBio, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo

Oct 01, 2025

Oct 01, 2025

AnaptysBio (NASDAQ:ANAB) Shares Up 8.9% on Analyst Upgrade - MarketBeat

Oct 01, 2025

Oct 01, 2025

AnaptysBio Charts Path To Split Into Two Public Companies By 2026 - Sahm

Oct 01, 2025

Oct 01, 2025

AnaptysBio (NASDAQ:ANAB) Price Target Raised to $59.00 at HC Wainwright - Defense World

Oct 01, 2025

Oct 01, 2025

AnaptysBio (NASDAQ:ANAB) Shares Gap Up on Analyst Upgrade - Defense World

Oct 01, 2025

Sep 30, 2025

A house dividing: Anaptysbio wants separate pipeline, royalty firms - BioWorld MedTech

Sep 30, 2025

Sep 30, 2025

AnaptysBio Announces Business Separation Plans - The Globe and Mail

Sep 30, 2025

Sep 30, 2025

AnaptysBio Stock Rise: Analyzing Latest Developments - timothysykes.com

Sep 30, 2025

Sep 30, 2025

AnaptysBio Split Will Establish Separate Royalty And Biopharma Firms - insights.citeline.com

Sep 30, 2025

Sep 30, 2025

Biggest stock movers Tuesday: WOLF, UUUU, FLY, and more - MSN

Sep 30, 2025

Sep 30, 2025

AnaptysBio climbs after Leernik raises PT on investor-friendly spinoff plans - TradingView

Sep 30, 2025

Sep 30, 2025

AnaptysBio Stock Gets A Price Target Hike After Announcing Plan To Separate Royalty, Biopharma Businesses – Check Out The New Level - Stocktwits

Sep 30, 2025

Sep 30, 2025

J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating - 富途牛牛

Sep 30, 2025

Sep 30, 2025

AnaptysBio rises on plans to split company - The Pharma Letter

Sep 30, 2025

Sep 30, 2025

AnaptysBio stock price target raised to $37 from $32 at Leerink Partners - Investing.com Canada

Sep 30, 2025